Ritonavir CAS 155213-67-5: A Comprehensive Guide to its Properties, Applications, and Market Significance
Explore the critical role of Ritonavir in modern medicine, from HIV treatment to emerging viral therapies.
Get a Quote & SampleProduct Core Value
Ritonavir
Ritonavir (CAS 155213-67-5) is a vital pharmaceutical intermediate renowned for its potent antiviral properties and its significant role as a pharmacokinetic enhancer. Its chemical structure, C37H48N6O5S2, and molecular weight of 720.94 g/mol contribute to its efficacy in inhibiting HIV protease and boosting the effectiveness of other antiretroviral drugs.
- Explore the intricate Ritonavir HIV treatment mechanism to understand its therapeutic impact.
- Learn about the latest advancements in Ritonavir COVID-19 application, showcasing its versatility.
- Discover reliable sources for Ritonavir pharmaceutical intermediate suppliers, ensuring quality procurement.
- Gain insights into the detailed Ritonavir CAS 155213-67-5 properties, including its physical and chemical characteristics.
Key Advantages It Brings
Enhanced Therapeutic Efficacy
Ritonavir acts as a crucial pharmacokinetic enhancer, significantly improving the therapeutic outcomes of other antiretroviral medications by boosting their plasma concentrations and prolonging their activity, thus optimizing Ritonavir treatment for HIV-1.
Broad-Spectrum Antiviral Potential
Beyond its established role in HIV treatment, Ritonavir demonstrates potential as a SARS-CoV-2 inhibitor, highlighting its broad-spectrum antiviral capabilities and its ongoing research in combating emerging infectious diseases, including its Ritonavir COVID-19 application.
Pharmaceutical Supply Chain Reliability
Understanding the global market for Ritonavir pharmaceutical intermediate suppliers is key for consistent production and availability, ensuring that this critical component is accessible for ongoing research and manufacturing.
Key Applications
HIV/AIDS Treatment
Ritonavir is a cornerstone in the management of HIV infection, often used in combination therapies to enhance the potency and efficacy of other antiretroviral drugs, a testament to its Ritonavir HIV treatment mechanism.
COVID-19 Therapeutics Research
Emerging research indicates Ritonavir's potential in combination therapies for COVID-19, marking a significant development in its therapeutic application and underscoring its importance in antiviral drug development.
Pharmaceutical Intermediate Manufacturing
As a key intermediate, Ritonavir is integral to the synthesis of complex pharmaceutical compounds, supporting the broader pharmaceutical industry's ability to develop life-saving medications.
Antiviral Drug Development
The study of Ritonavir's properties and mechanisms continues to inform the development of new antiviral agents, contributing to the ongoing fight against various viral diseases.